Emcure Pharmaceuticals' Q3 Revenue Hits ₹19.63 Billion, Net Profit Surges to ₹1.54 Billion

Emcure Pharma reported a robust 35% increase in net profit, reaching ₹1.54 billion for the third quarter of the current financial year. The company's revenue from operations also saw a significant jump of nearly 18% year-on-year, climbing to ₹19.63 billion. This strong performance highlights Emcure Pharma's growth in the pharmaceutical sector. The company's last quarter net profit was ₹201.55 Cr. These figures reflect the company's financial health and market position. 

 

Source: Moneycontrol, BlinkX